Revolution Medicines (RVMDW) Competitors $0.14 0.00 (0.00%) (As of 09/27/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends RVMDW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCAX, BCTXW, CDIOW, CTCXW, and CELUWShould you be buying Revolution Medicines stock or one of its competitors? The main competitors of Revolution Medicines include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), Bicara Therapeutics (BCAX), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry. Revolution Medicines vs. 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical Apollomics Bicara Therapeutics BriaCell Therapeutics Cardio Diagnostics Carmell Celularity 180 Life Sciences (NASDAQ:ATNFW) and Revolution Medicines (NASDAQ:RVMDW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, community ranking, profitability, earnings, risk, media sentiment, institutional ownership and valuation. Which has preferable earnings & valuation, ATNFW or RVMDW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ARevolution Medicines$742KN/AN/AN/AN/A Does the media refer more to ATNFW or RVMDW? In the previous week, 180 Life Sciences had 1 more articles in the media than Revolution Medicines. MarketBeat recorded 2 mentions for 180 Life Sciences and 1 mentions for Revolution Medicines. Revolution Medicines' average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.44 indicating that Revolution Medicines is being referred to more favorably in the news media. Company Overall Sentiment 180 Life Sciences Positive Revolution Medicines Very Positive Does the MarketBeat Community prefer ATNFW or RVMDW? 180 Life Sciences and Revolution Medicines both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ARevolution MedicinesN/AN/A Is ATNFW or RVMDW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Revolution Medicines N/A N/A N/A Do analysts recommend ATNFW or RVMDW? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 180 Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ARevolution Medicines 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A SummaryRevolution Medicines beats 180 Life Sciences on 2 of the 3 factors compared between the two stocks. Ad Behind the MarketsRetire off just one stock ticker?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT make you rich. However, there is one stock that stands head and shoulders above everything else. It's currently trading for only $15...Click here for the ticker >>> Get Revolution Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for RVMDW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVMDW vs. The Competition Export to ExcelMetricRevolution MedicinesBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$236.31M$5.56B$8.55BDividend YieldN/A3.48%3.71%4.07%P/E RatioN/A230.60126.9318.68Price / SalesN/A14,468.551,728.0086.23Price / CashN/A11.6139.4633.61Price / BookN/A8.814.914.57Net IncomeN/A-$25.75M$116.76M$225.32M7 Day PerformanceN/A0.04%4.94%4.15%1 Month PerformanceN/A20.21%13.26%7.99%1 Year PerformanceN/A27.70%22.89%17.82% Revolution Medicines Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVMDWRevolution MedicinesN/A$0.14flatN/AN/A$0.00$742,000.000.00378Positive NewsATNFW180 Life SciencesN/A$0.01flatN/A-43.6%$0.00N/A0.007Short Interest ↓Gap DownSXTPW60 Degrees PharmaceuticalsN/A$0.04flatN/A-78.9%$0.00$418,304.000.002DRTSWAlpha Tau MedicalN/A$0.20-4.9%N/AN/A$0.00N/A0.0080Short Interest ↓WENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownAPLMWApollomicsN/A$0.01flatN/A-81.5%$0.00N/A0.0059Short Interest ↓BCAXBicara TherapeuticsN/A$25.53-0.3%N/AN/A$0.00N/A0.0032Positive NewsBCTXWBriaCell TherapeuticsN/A$0.28+17.0%N/A-84.7%$0.00N/A0.008Short Interest ↓News CoverageGap DownCDIOWCardio DiagnosticsN/A$0.03flatN/A-19.6%$0.00$39,138.000.007Short Interest ↓News CoverageCTCXWCarmellN/A$0.06flatN/AN/A$0.00$12,320.000.009CELUWCelularityN/A$0.02flatN/A-15.5%$0.00$22.77M0.00220 Related Companies and Tools Related Companies: 180 Life Sciences Competitors 60 Degrees Pharmaceuticals Competitors Alpha Tau Medical Competitors Anew Medical Competitors Apollomics Competitors Bicara Therapeutics Competitors BriaCell Therapeutics Competitors Cardio Diagnostics Competitors Carmell Competitors Celularity Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RVMDW) was last updated on 9/28/2024 by MarketBeat.com Staff From Our PartnersThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | Sponsored10X More Profitable Than Physical Gold?The smart money is piling into gold and gold stocks. There's a backdoor gold play that could deliver 10 TIM...Monument Traders Alliance | SponsoredFed Triggers Boom: Buy this Play on Elon’s New AIHave you seen Elon Musk's new invention? I was already very bullish on this new type of AI. And now that...InvestorPlace | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the ...Porter & Company | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revolution Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revolution Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RVMDW Stock Alerts